Clinical Trial Update: A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics and Clinical Activity of Imetelstat in Combination With Ruxolitinib in Participants With Myelofibrosis [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the safety, pharmacokinetics, pharmacodynamics, and clinical activity of imetelstat in combination with ruxolitinib in participants wit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelofibrosis

Drugs mentioned

• Imetelstat (imetelstat)
• Ruxolitinib (ruxolitinib)

Snippet

Sponsor: Geron Corporation | Conditions: Myelofibrosis | Phase 1 | Status: RECRUITING